Rationale for targeting complement in COVID‐19
Review
[키워드] activated
Activation
acute lung injury
acute respiratory distress
acute respiratory illness
ARDS
cascade
caused
cell entry
China
clinical trials
clinically
collected
Community
complement
complement pathways
complement proteins
component
COVID‐19
COVID‐19
Cytokine storm
disease
dysfunction
evade
Evidence
health emergency
immunology
Immunopathogenesis
immunopathology
Infection
information
innate immune
lectin pathway
Macrophage
manifestation
Microbiology, Virology & Host Pathogen Interaction
Mild
multiorgan failure
neutrophil
Novel coronavirus
offer
Pathogens
potential therapeutic agent
rationale
SARS‐CoV‐1
SARS‐CoV‐2
SARS‐CoV‐2
Sepsis
Spread
Support
syndrome
therapeutic
Therapeutic strategies
Therapeutics
virus
[DOI] 10.15252/emmm.202012642 PMC 바로가기 [Article Type] Review
[DOI] 10.15252/emmm.202012642 PMC 바로가기 [Article Type] Review